Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 142 citing articles:

NK Cell-Based Immune Checkpoint Inhibition
Muhammad Khan, Sumbal Arooj, Hua Wang
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 283
NK cells and ILCs in tumor immunotherapy
Simona Sivori, Daniela Pende, Linda Quatrini, et al.
Molecular Aspects of Medicine (2020) Vol. 80, pp. 100870-100870
Open Access | Times Cited: 199
Natural Killer Cells: From Innate to Adaptive Features
Adriana M. Mujal, Rebecca B. Delconte, Joseph C. Sun
Annual Review of Immunology (2021) Vol. 39, Iss. 1, pp. 417-447
Open Access | Times Cited: 138
Natural killer cells: a promising immunotherapy for cancer
Junfeng Chu, Fengcai Gao, Meimei Yan, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 114
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023
Johanna Latzka, Chalid Assaf, M. Bagot, et al.
European Journal of Cancer (2023) Vol. 195, pp. 113343-113343
Open Access | Times Cited: 69
IGSF8 is an innate immune checkpoint and cancer immunotherapy target
Yulong Li, Xiangyang Wu, Caibin Sheng, et al.
Cell (2024) Vol. 187, Iss. 11, pp. 2703-2716.e23
Closed Access | Times Cited: 17
The Rise of NK Cell Checkpoints as Promising Therapeutic Targets in Cancer Immunotherapy
Haoyu Sun, Cheng Sun
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 88
Inhibitory Receptors and Checkpoints in Human NK Cells, Implications for the Immunotherapy of Cancer
Simona Sivori, Mariella Della Chiesa, Simona Carlomagno, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 81
Targeting NK Cell Checkpoint Receptors or Molecules for Cancer Immunotherapy
Cai Zhang, Yuxia Liu
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 76
KIR Receptors as Key Regulators of NK Cells Activity in Health and Disease
Joanna Dębska-Zielkowska, Grażyna Moszkowska, Maciej Zieliński, et al.
Cells (2021) Vol. 10, Iss. 7, pp. 1777-1777
Open Access | Times Cited: 75
Single-cell transcriptomics links malignant T cells to the tumor immune landscape in cutaneous T cell lymphoma
Xiangjun Liu, Shanzhao Jin, Simeng Hu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 57
S2k‐Guidelines – Cutaneous lymphomas (ICD10 C82 ‐ C86): Update 2021
Edgar Dippel, Chalid Assaf, Jürgen C. Becker, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2022) Vol. 20, Iss. 4, pp. 537-554
Open Access | Times Cited: 40
Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study
Adèle de Masson, M. Beylot‐Barry, C. Ram‐Wolff, et al.
The Lancet (2023) Vol. 401, Iss. 10392, pp. 1941-1950
Open Access | Times Cited: 36
Natural Killer Cell Engagers (NKCEs): a new frontier in cancer immunotherapy
Minchuan Zhang, Kong‐Peng Lam, Shengli Xu
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 24
Targeting natural killer cells: from basic biology to clinical application in hematologic malignancies
Juanjuan Shang, Shunfeng Hu, Xin Wang
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Single-cell RNA sequencing reveals markers of disease progression in primary cutaneous T-cell lymphoma
Katharina Rindler, Constanze Jonak, Natalia Alkon, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 44
Therapeutic strategies for gastric cancer targeting immune cells: Future directions
Yan Zhao, Yuansong Bai, Meili Shen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 29
Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 study
Jan P. Nicolay, Susanne Melchers, J. Albrecht, et al.
Blood (2023) Vol. 142, Iss. 9, pp. 794-805
Open Access | Times Cited: 21
Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study
A. Bozonnat, M. Beylot‐Barry, O. Dereure, et al.
EClinicalMedicine (2024) Vol. 73, pp. 102679-102679
Open Access | Times Cited: 7
Novel targeted therapies of T cell lymphomas
Katarzyna Iżykowska, Karolina Rassek, Dorota Korsak, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 49
Advances and Perspectives in the Treatment of T-PLL
Till Braun, Jana von Jan, Linus Wahnschaffe, et al.
Current Hematologic Malignancy Reports (2020) Vol. 15, Iss. 2, pp. 113-124
Open Access | Times Cited: 44
Pathogenesis and Therapy of Primary Cutaneous T-Cell Lymphoma: Collegium Internationale Allergologicum (CIA) Update 2020
Małgorzata Bobrowicz, Christina Fassnacht, Desislava Ignatova, et al.
International Archives of Allergy and Immunology (2020) Vol. 181, Iss. 10, pp. 733-745
Open Access | Times Cited: 43
Novel Treatments of Adult T Cell Leukemia Lymphoma
Hiba El Hajj, Kunihiro Tsukasaki, Morgane Cheminant, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 41
Natural killer (NK) cell-based immunotherapies and the many faces of NK cell memory: A look into how nanoparticles enhance NK cell activity
Idoia Mikelez-Alonso, Susana Magadán, África González‐Fernández, et al.
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113860-113860
Closed Access | Times Cited: 41
Mycosis Fungoides and Sézary Syndrome: An Integrative Review of the Pathophysiology, Molecular Drivers, and Targeted Therapy
Nuria García‐Díaz, Miguel Á. Piris, Pablo L. Ortiz‐Romero, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1931-1931
Open Access | Times Cited: 38
Page 1 - Next Page

Scroll to top